Previous Episode: Taking the First Step: A Discussion on Mental Health
Next Episode: Lay Your Questions About Sleep and Naps to Rest
Booth Gardner Parkinson's Care Center is conducting a study to evaluate the clinical effects, safety and tolerability of ATH-1017 in subjects with Parkinson's disease dementia (PDD). ATH-1017 is an experimental treatment for Alzheimer's disease (AD) and Parkinson's disease dementia (PDD), formulated as a sterile solution for subcutaneous (SC) injection.
